Heart Disease Clinical Trials in Baltimore

Showing 241-260 of 287 trials

Problem Solving and Cardiovascular Disease Risk Management in Diabetic Blacks

NCT00201110

The purpose of this study is to test a measurement tool and a new training intervention for problem solving in self-management of high cardiovascular disease (CVD) risk in African Americans with type 2 diabetes.

Cardiovascular DiseasesHeart DiseasesDiabetes Mellitus, Type 2+1 more

Johns Hopkins University139 participantsStarted Jul 2004

Baltimore, Maryland, United States

COMPLETEDPHASE1< 1 mile

Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease

NCT01107912

The 5-milligram (mg) maintenance dose (MD) of prasugrel in very elderly patients with coronary artery disease produces a pharmacodynamic response within the same therapeutic range as 10-mg MD in non-elderly patients.

Coronary Artery Disease

Eli Lilly and Company155 participantsStarted Mar 2010

Jacksonville, Florida, United States • Baltimore, Maryland, United States • Cincinnati, Ohio, United States +4 more locations

Problem Solving and Cardiovascular Disease Risk Management in Diabetic Blacks

Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease

Heart Disease Trials in Other Cities

Fast Food Study: Assessment of the Effects of Fast-Food on Inflammatory Markers

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac Stimulation

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

Registry Experience at the Washington Hospital Center, Des - Taxus Liberte Versus Xience V

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)

The Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation, Coronary Artery Bypass Graft Surgery,or Implantation of Left Ventricular Assist Devices

The Epidemiology of Ventricular Assist Device-Related Infections

Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]

Physiological Response to Exercise: Sensor Evaluation at Specified Exertions

Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure

Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

Other Conditions in Baltimore